Cite
APA Citation
Han, B., Li, K., Chu, T., Bi, M., Zhang, H., Yu, Y., Shi, J., Zhang, X., Chen, Z., Han, C., & Bai, T. (n.d.). 396OA multi-center, randomized, double-blind, parallel, two-group phase III trial on the efficacy and safety of QL1101 or bevacizumab in combination with paclitaxel and carboplatin in first-line treatment of non-squamous non-small cell lung cancer. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095521938.0x000039